Treximo News

CHICAGO, IL (October 19, 2020) — Treximo, a leading global life sciences consulting and solutions provider and part of The Planet Group, announced today that Scott Williams has joined the firm as Vice President of Business Development. Williams previously held the role of Vice President of Sales and Operations serving in the Life Sciences industries…

Read More

In the era of technological disruption, data science is a disruptor for the books. Today’s data scientists develop processes, algorithms, and systems to mine structured and unstructured data with the end goal of finding useful insights that deliver better products, workplace processes, and profit for the company, as well as consumer experiences. While financial, energy,…

Read More

Drug development can be a protracted and multifaceted process. This is often the case for startups and newer organizations, which may not have dedicated regulatory compliance departments and established standard operating procedures (SOPs).  These organizations may seek regulatory consulting services to support submission strategies and develop the required procedures. According to Professor Thomas Koperniak of…

Read More

COVID-19 has been the ultimate big pharma catalyst, as well as the biggest thing to hit biopharmaceutical news pages in decades. On the industry side, however, investors and observers remain mindful of non-COVID-related trends in biopharma. More accurately, trends well underway in January still deserve attention.  2020 Biopharma Trends to Keep an Eye On These…

Read More

It’s no wonder scientists begin clinical trials with great excitement: combine promising discoveries with the best test sites, scientists, and as many qualified, willing patients as possible, and off you go to hypothesis validation.  Along the way, however, even the best drugs and devices hit roadblocks.  Like a manned space mission, every clinician needs near-flawless…

Read More
Woman working in a life sciences lab

Today, with the FDA endorsing fewer new treatments, life sciences companies are pressured to develop better therapies while also struggling to control costs and retain their star employees. And while some companies solve problems with more resources, more staff, and more funding, the answer for others is less. First used in the auto industry, “lean…

Read More

In the latest PMI report Pulse of the Profession 2020 (2020), 11.4% of surveyed organizations attribute investment waste to poor project performance.  What defines project performance and ultimately its success is the completion of the intended goals on time and within budget. As simple as it sounds, organizations still fail in many of their programs…

Read More

Drug and medical device development and manufacturing is a complex process that involves multiple supply chains, various monitoring systems, and countless players from R&D to market. Due to the sensitive nature of the products and the repercussions should anything go awry during production or distribution, the medical industry is under constant pressure for attention to…

Read More

In 2017, R&D investments in the pharmaceutical space reached more than $70 billion, with projected figures of over $200 billion by 2024. Pharma is one of the two sectors with semiconductors that are heavily reinvesting its revenue in research and development (15% to 20% on average). Considering the cost explosion of developing a new drug…

Read More

Spending on prescription drugs in the United States is expected to reach $600 billion by 2023. The continuously increasing need for pharmaceuticals is mostly driven by an aging population, a rise in chronic pathologies, and lifestyle changes that lead to poorer health. In this highly competitive landscape, a few giants dominate the industry, leaving a…

Read More